期刊文献+

结肠癌中COX-2表达及其与肿瘤脉管生成的关系 被引量:2

Expression of COX-2 and its relationship with angiogenesis/lymphangiogenesis in colon cancer
下载PDF
导出
摘要 目的探讨结肠癌中环氧化酶2(COX-2)表达的意义及其与血管r8皮生长因子C(VEGF—C)、微血管密度(MVD)和微淋巴管密度(MLD)的关系。方法采用免疫组化EnVision法检测56例结肠癌中COX-2、VEGF—C、CD34和D2-40的表达。结果COX-2、VEGF—C在结肠癌中的阳性率分别为69.6%(39/56)和66.1%(37/56);COX-2与组织学分级、浸润深度、淋巴结转移、Dukes分期相关(P〈0.05),与性别、肿瘤大小无关(P〉0.05);VEGF—C与浸润深度、淋巴结转移、Dukes分期相关(P〈0.05)。与性别、肿瘤大小、组织学分级无关(P〉O.05):COX-2、VEGF—C表达阳性组的MVD、MLD均明显高于阴性组(P〈0.01);COX-2与VEGF—C呈正相关(P〈0.01);MVD与MLD无关(P〉O.05)。结论COX-2可作为结肠癌恶性程度及预后判断的参考指标,其可能通过上调VEGF-C的表达以促进肿瘤血管及淋巴管生成而参与结肠癌的浸润转移。 Objective To investigate the expression of cyclooxygenase-2 (COX-2) and its relationship with angiogene- sis/lymphangiogenesis in colon cancer. Methods Immunohistochemical staining EnVision method was used to detect the expression of COX-2, vascular endothelial growth factor-C(VEGF-C), CD34 and D2-40 in 56 cases of colon cancer. Results The positive rates of COX-2 and VEGF-C in colon cancer was 69.6% (39/56) and 66.1% (37/56) respectively. The expression of COX-2 was correlated with histological grade, invasive depth, lymphatic metastasis and Dukes' stage (P〈0.05), not with sex and tumor size(P 〉0.05). The expression of VEGF-C was correlated with invasive depth, lymphatic metastasis and Dukes' stage (P〈 0.05), not with sex, tumor size and histological grade(P 〉0.05). The microvessel density (MVD) and microlymphatic density (MLD) in cases with positive COX-2 and VEGF-C expression were significantly higher than those without COX-2 and VEGF-C expres- sion (P〈0.01). The expression of COX-2 was correlated with VEGF-C (P〈0.01). MVD was not correlated with MLD (P 〉0.05). Conclusion COX-2 can be used as a reference marker for assessment of differentiation and prognosis of colon cancer, which may be associated with upregulation of VEGF-C and vascularization in the tumors.
出处 《浙江医学》 CAS 2012年第20期1644-1646,共3页 Zhejiang Medical Journal
基金 温州市卫生局科研项目(2011B074)
关键词 结肠肿瘤 环氧化酶2 血管内皮生长因子C 血管生成 淋巴管生成 Colon tumors Cyclooxygenase-2 Vascular endothelial growth factor-C Angiogenesis Lymphangiogenesis
  • 相关文献

参考文献5

二级参考文献30

  • 1郑敏,Simon R,Kononen J,Sauter G,Mihatsch MJ,Moch H.使用cDNA微阵列和组织微阵列对三种上皮性卵巢肿瘤基因表达的分析[J].癌症,2004,23(7):771-776. 被引量:8
  • 2陈俭,来茂德.COX-2与结直肠癌早期发病的关系[J].临床与实验病理学杂志,2004,20(4):470-473. 被引量:7
  • 3Cheng-BoHan,Xiao-YunMao,YanXin,Shao-ChengWang,Jia-MingMa,Yu-JieZhao.Quantitative analysis of tumor mitochondrial RNA using microarray[J].World Journal of Gastroenterology,2005,11(1):36-40. 被引量:4
  • 4Xiao-Yun Mao,Xiao-Ge Wang,Xiao-Jun Lv,Lei Xu,Cheng-Bo Han.COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray[J].World Journal of Gastroenterology,2007,13(25):3466-3471. 被引量:46
  • 5Chen W S, Wei S J, Liu J M, et al. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac [J]. Int J Cancer, 2001,91 (6) :894-899.
  • 6Wendum D, Masliah J, Trugnan G, et al. Cyclooxygenase-2 and its role in colorectal cancer development [J]. Virchows Arch, 2004, 445(4) :327-333.
  • 7Karkkainen M J, Petrova T V. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis [ J]. Oneogene, 2000, 19 (49) : 5598-5605.
  • 8Chu A J, Chou T H, Chen B D. Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications [J]. Front Biosei, 2004,9 : 2697-2713.
  • 9Soumaoro L T, Uetake H, Takagi Y, et al. Cyclooxygenase-2 expression : a significant prognostic indicator for patients with colorectal cancer [J]. Clin Cancer Res, 2004, 10(24) :8465-8471.
  • 10Murata H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma [ J]. Am J Gastroenterol, 1999,94 (2) : 451-455.

共引文献59

同被引文献23

  • 1Bakhle YS. COX-2 and cancer: a new approach to an old problem[J]. Br J Pharmacol,2001,134(6) : 1137-1150.
  • 2Palazon A,Martinez-Forero I,Teijeira A,et al. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD 137 (4-1B B ) for immunotherapy[J]. Cancer Discov, 2012,2 (7) : 608-623.
  • 3Hansen T F, Sφrensen F B, Lindebjerg J, eta of microRNA-126 in relation to first capecitabine and oxaliplatin in patients with cancer[J]. BMC cancer ,2012, 12(1):83. The predictive value ine treatment with metastatic colorectal.
  • 4Gulhati P, Bowen K A, Liu J, et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Racl signaling pathways[J]. Cancer research, 2011, 71(9):3246- 3256.
  • 5Shang J, Fu Y, Wang Y, et al. MicroRNA-23a Antisense Enhances 5-Fluorouracil Chemosensitivity Through APAF-1/Caspase-9 Apoptotic Pathway in Colorectal Cancer Cells[J]. Journal of Cellu- lar Biochemistry, 2014, 115(4):772-784.
  • 6Dong Q, Cai N, Tao T, et al. An Axis Involving SNAIl, microRNA- 128 and SP1 Modulates Glioma Progression[J]. PIoS one, 2014, 9(6):e98651.
  • 7Min J, Tao Z, Can L, et al. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating celts[J]. Cancer Research, 2014, 74(15):4183-4195.
  • 8Donzelli S, Fontemaggi G, Fazi F, et al. MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function[J]. Cell Death & Differentiation, 2011, 19(6):1038-1048.
  • 9Ivanovska I, Ball A S, Diaz R L, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression[J]. Molecular and cellular biology, 2008, 28(7):2167-2174.
  • 10吕明芬,黄卡特,李秉煦,徐云升.Foxp1及Ki-67在皮肤基底细胞癌的表达[J].中国麻风皮肤病杂志,2011,27(5):311-313. 被引量:5

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部